Deciphera Pharmaceuticals, Inc. (DCPH): Price and Financial Metrics

Deciphera Pharmaceuticals, Inc. (DCPH)

Today's Latest Price: $54.57 USD

0.72 (1.34%)

Updated Feb 26 1:28pm

Add DCPH to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 338 in Biotech

See all "A" rated Strong Buy stocks

DCPH Stock Summary

  • DCPH's price/sales ratio is 133.49; that's higher than the P/S ratio of 98.19% of US stocks.
  • With a year-over-year growth in debt of -91.12%, Deciphera Pharmaceuticals Inc's debt growth rate surpasses only 2.66% of about US stocks.
  • In terms of volatility of its share price, DCPH is more volatile than 93.77% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Deciphera Pharmaceuticals Inc are RETA, SYBX, RCUS, OTIC, and ORMP.
  • DCPH's SEC filings can be seen here. And to visit Deciphera Pharmaceuticals Inc's official web site, go to
DCPH Daily Price Range
DCPH 52-Week Price Range

DCPH Stock Price Chart More Charts

DCPH Price/Volume Stats

Current price $54.57 52-week high $71.11
Prev. close $53.85 52-week low $19.88
Day low $53.94 Volume 103,052
Day high $55.19 Avg. volume 540,835
50-day MA $63.23 Dividend yield N/A
200-day MA $40.49 Market Cap 2.96B

Deciphera Pharmaceuticals, Inc. (DCPH) Company Bio

Deciphera Pharmaceuticals LLC develops and manufactures kinase inhibitor treatments for cancer by cutting off the ability of tumor cells to thrive and spread. Its product pipeline includes Altiratinib (DCC-2701), a MET/TIE2/VEGFR2/TRK kinase inhibitor; DCC-2618, a pan-KIT inhibitor; Rebastinib, a TIE2/VEGFR1 kinase inhibitor; and LY3009120 (DP-4978), a pan-RAF inhibitor. The company was founded in 2003 and is based in Waltham, Massachusetts.

DCPH Latest News Stream

Event/Time News Detail
Loading, please wait...

DCPH Latest Social Stream

Loading social stream, please wait...

View Full DCPH Social Stream

DCPH Price Returns

1-mo -16.59%
3-mo 16.08%
6-mo 50.41%
1-year 90.21%
3-year N/A
5-year N/A
YTD -12.32%
2019 196.52%
2018 -7.41%
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6461 seconds.